nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Carmustine—malignant glioma	0.768	1	CbGbCtD
Triamterene—SCNN1D—telencephalon—malignant glioma	0.0106	0.195	CbGeAlD
Triamterene—SCNN1B—Ion channel transport—ATP1B2—malignant glioma	0.01	0.0564	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—ATP1B2—malignant glioma	0.01	0.0564	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—ATP1B2—malignant glioma	0.01	0.0564	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—ATP1B2—malignant glioma	0.01	0.0564	CbGpPWpGaD
Triamterene—SCNN1A—telencephalon—malignant glioma	0.00829	0.152	CbGeAlD
Triamterene—SCNN1D—central nervous system—malignant glioma	0.00603	0.111	CbGeAlD
Triamterene—SCNN1G—cerebellum—malignant glioma	0.0059	0.108	CbGeAlD
Triamterene—SCNN1D—cerebellum—malignant glioma	0.0059	0.108	CbGeAlD
Triamterene—SCNN1B—central nervous system—malignant glioma	0.0051	0.0937	CbGeAlD
Triamterene—SCNN1D—brain—malignant glioma	0.00479	0.088	CbGeAlD
Triamterene—SCNN1A—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00436	0.0245	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00436	0.0245	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00436	0.0245	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00436	0.0245	CbGpPWpGaD
Triamterene—SCNN1B—brain—malignant glioma	0.00405	0.0744	CbGeAlD
Triamterene—SCNN1B—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00399	0.0224	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00399	0.0224	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00399	0.0224	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00399	0.0224	CbGpPWpGaD
Triamterene—SCNN1A—brain—malignant glioma	0.00374	0.0687	CbGeAlD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00349	0.0196	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00349	0.0196	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00349	0.0196	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00349	0.0196	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—APOD—malignant glioma	0.00339	0.0191	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—APOD—malignant glioma	0.00339	0.0191	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—APOD—malignant glioma	0.00339	0.0191	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—APOD—malignant glioma	0.00339	0.0191	CbGpPWpGaD
Triamterene—SCNN1D—Stimuli-sensing channels—RAF1—malignant glioma	0.00303	0.017	CbGpPWpGaD
Triamterene—SCNN1B—Stimuli-sensing channels—RAF1—malignant glioma	0.00303	0.017	CbGpPWpGaD
Triamterene—SCNN1A—Stimuli-sensing channels—RAF1—malignant glioma	0.00303	0.017	CbGpPWpGaD
Triamterene—SCNN1G—Stimuli-sensing channels—RAF1—malignant glioma	0.00303	0.017	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—POR—malignant glioma	0.00297	0.0167	CbGpPWpGaD
Triamterene—CYP1A2—Xenobiotics—CYP2B6—malignant glioma	0.00252	0.0142	CbGpPWpGaD
Triamterene—CYP1A2—Xenobiotics—CYP2C18—malignant glioma	0.00218	0.0123	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—RAF1—malignant glioma	0.00198	0.0111	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—RAF1—malignant glioma	0.00198	0.0111	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—RAF1—malignant glioma	0.00198	0.0111	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—RAF1—malignant glioma	0.00198	0.0111	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—ASMT—malignant glioma	0.00182	0.0102	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00174	0.00977	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00174	0.00977	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00174	0.00977	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00174	0.00977	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00165	0.00927	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00159	0.00897	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00159	0.00897	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00159	0.00897	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00159	0.00897	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00152	0.00854	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00152	0.00854	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00152	0.00854	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00152	0.00854	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.00126	0.00708	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	0.00112	0.00631	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.00112	0.00631	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00105	0.00589	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00103	0.00581	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000907	0.0051	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000895	0.00504	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000848	0.00477	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000795	0.00447	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.00079	0.00445	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000735	0.00414	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	0.000698	0.00393	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000688	0.00387	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000688	0.00387	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000688	0.00387	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000688	0.00387	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	0.000612	0.00344	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.000581	0.00327	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000557	0.00314	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	0.00054	0.00304	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000527	0.00297	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	0.00045	0.00253	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	0.000444	0.0025	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	0.00039	0.0022	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	0.000385	0.00217	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	0.000374	0.00211	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.00034	0.00191	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	0.000338	0.0019	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000337	0.00189	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000326	0.00183	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTT1—malignant glioma	0.000316	0.00178	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000305	0.00171	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000303	0.00171	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000302	0.0017	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000296	0.00167	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000257	0.00144	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000236	0.00133	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000231	0.0013	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000231	0.0013	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—RTEL1—malignant glioma	0.000221	0.00125	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.00022	0.00124	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.00022	0.00124	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTP1—malignant glioma	0.000219	0.00123	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000218	0.00123	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	0.000216	0.00122	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000158	0.00089	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000153	0.000861	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—COX8A—malignant glioma	0.000127	0.000715	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000114	0.00064	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ASMT—malignant glioma	0.000108	0.000608	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000106	0.000595	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—BCAN—malignant glioma	0.000102	0.000572	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—IDH2—malignant glioma	8.19e-05	0.000461	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.72e-05	0.000435	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2B6—malignant glioma	7.7e-05	0.000433	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—IDH1—malignant glioma	7.04e-05	0.000396	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SPHK1—malignant glioma	6.82e-05	0.000384	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2C18—malignant glioma	6.68e-05	0.000376	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.3e-05	0.000354	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.73e-05	0.000323	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.53e-05	0.000312	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTT1—malignant glioma	5.4e-05	0.000304	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS1—malignant glioma	5.06e-05	0.000285	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.04e-05	0.000284	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—BCHE—malignant glioma	4.7e-05	0.000265	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC5A5—malignant glioma	4.65e-05	0.000262	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.39e-05	0.000247	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.35e-05	0.000245	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.8e-05	0.000214	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTP1—malignant glioma	3.74e-05	0.000211	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CAT—malignant glioma	3.64e-05	0.000205	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NCOR1—malignant glioma	3.44e-05	0.000194	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CAV1—malignant glioma	2.8e-05	0.000158	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.68e-05	0.000151	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.55e-05	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARG—malignant glioma	2.46e-05	0.000139	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.25e-05	0.000126	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.96e-05	0.00011	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—malignant glioma	1.94e-05	0.000109	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTEN—malignant glioma	1.69e-05	9.52e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.19e-05	6.72e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—malignant glioma	9.75e-06	5.49e-05	CbGpPWpGaD
